Market by Device Type, Application, Detection and Prediction Device Type, End-user, and Country Outlook | Forecast 2022-2028
According to Triton’s report, the epilepsy devices market in North America is expected to display a compound annual growth rate of 8.34% during the forecast period from 2022 to 2028.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries assessed in the region consist of:
•
The United States
•
Canada
The United States holds the highest shares in the epilepsy devices market. Developed healthcare infrastructure, favorable government policies, and the presence of key companies are major factors that drive the region’s market. Estimates indicate that around 1.2% of the US population will have active epilepsy in their lifetime.. This has influenced key players like Empatica and Cadwell to invest in R&D to develop new products and gain approvals. Therefore, such steps are anticipated to generate lucrative opportunities for the epilepsy devices market over the forecast period.
In the United States, patients diagnosed with
epilepsy experience depression and other psychological conditions, increasing
the risk of mortality. Moreover, the elderly population is vulnerable to
various conditions, including epilepsy seizures. This has resulted in the
development of portable technology. Estimates suggest that the burden of
neurological diseases is anticipated to increase over the upcoming years,
further elevating the risk of seizures. Thus, as stated above, these factors
widen the scope and growth of the epilepsy devices market.
Similarly, epilepsy cases among the elderly are
a major concern in Canada. Several patients also go through social isolation,
psychological issues, and unemployment. This has compelled players to develop
new products, which will open avenues for the epilepsy devices market.
Further, several patients opt for alternative
treatment due to refractory epilepsy, wherein medication does not improve the
condition. Implantable medical devices are one such alternative that helps by
integrating brain devices with local and cloud computing resources. The market’s expansion is determined as per
device type, end-user, application, and detection and prediction device type.
The device type segment is branched into implantable, traditional, and wearable
devices.
Cadwell
Industries Inc, Nihon Kohden Corporation, Medtronic Plc, and Boston Scientific
Corporation are among the key companies thriving in the epilepsy devices
market.
Cadwell Industries Inc is a neurodiagnostic
solutions company that offers EEG, IONM, and PSG products. The company launched
various solutions for sleep diagnostics, electrodiagnostic, and veterinary
medicine. With a sales and distribution network worldwide, it has international
teams across China, Singapore, the Netherlands, and Dubai. Cadwell has
headquarters located in Washington, US.
Key deliverables of the report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the epilepsy devices market revenue growth in North America and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the NA
epilepsy devices market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA EPILEPSY DEVICES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. GROWING
USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE
IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. COMFORT
& USABILITY
2.4.2. PRODUCT
FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. DEVELOPMENTS
& PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET
DRIVERS
2.10.1. COMBATING
EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING
PREVALENCE OF EPILEPSY
2.11. MARKET
CHALLENGES
2.11.1. UNAWARENESS
ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK
OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET
OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE
TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING
POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL
ADVANCES IN NON-INVASIVE WEARABLE SENSORS FOR EPILEPSY
3. NORTH
AMERICA EPILEPSY DEVICES MARKET OUTLOOK - BY DEVICE TYPE
3.1. TRADITIONAL
DEVICES
3.2. WEARABLE
DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA
DEVICES
3.2.4. MATTRESS
DEVICES
3.2.5. ANTI-SUFFOCATION
PILLOWS
3.2.6. OTHER
WEARABLE DEVICES
3.3. IMPLANTABLE
DEVICES
4. NORTH
AMERICA EPILEPSY DEVICES MARKET OUTLOOK - BY APPLICATION
4.1. VAGUS
NERVE STIMULATION
4.2. DEEP
BRAIN STIMULATION
4.2.1. MOVEMENT
DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE
NEUROSTIMULATION
5. NORTH
AMERICA EPILEPSY DEVICES MARKET OUTLOOK - BY DETECTION AND PREDICTION DEVICE
TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL
EEG
5.3. SURFACE
ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO
DETECTION SYSTEMS
5.6. ELECTRODERMAL
ACTIVITY
5.7. IMPLANTED
ADVISORY SYSTEMS
5.8. OTHER
DETECTION AND PREDICTION DEVICE TYPES
6. NORTH
AMERICA EPILEPSY DEVICES MARKET OUTLOOK - BY END-USER
6.1. HOSPITALS
& CLINICS
6.2. NEUROLOGY
CENTERS
6.3. HOMECARE
SETTINGS
6.4. OTHER
END-USERS
7. NORTH
AMERICA EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. UNITED
STATES
7.2. CANADA
8. COMPETITIVE
LANDSCAPE
8.1. LIVANOVA
PLC
8.2. NATUS
MEDICAL INCORPORATED
8.3. CADWELL
INDUSTRIES INC
8.4. NIHON
KOHDEN CORPORATION
8.5. COMPUMEDICS
LIMITED
8.6. MEDTRONIC
PLC
8.7. BOSTON
SCIENTIFIC CORPORATION
8.8. EMPATICA
INC
8.9. KONINKLIJKE
PHILIPS NV
8.10. NEUROPACE
INC
8.11. DRÄGERWERK
AG & CO KGAA
8.12. SHENZHEN
MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF
COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF
ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG
DEVICES
TABLE 9: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN
$ MILLION)
TABLE 14: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN
%)
FIGURE
5: NORTH AMERICA EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN
$ MILLION)
FIGURE
6: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
7: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028
(IN %)
FIGURE
8: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE
9: NORTH AMERICA EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $
MILLION)
FIGURE
10: NORTH AMERICA EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
11: NORTH AMERICA EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
12: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS,
2022-2028 (IN $ MILLION)
FIGURE
13: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028
(IN $ MILLION)
FIGURE
14: NORTH AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028
(IN $ MILLION)
FIGURE
15: NORTH AMERICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN
%)
FIGURE
16: NORTH AMERICA EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION,
2022-2028 (IN $ MILLION)
FIGURE
17: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028
(IN $ MILLION)
FIGURE
18: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021
& 2028 (IN %)
FIGURE
19: NORTH AMERICA EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN
$ MILLION)
FIGURE
20: NORTH AMERICA EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $
MILLION)
FIGURE
21: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $
MILLION)
FIGURE
22: NORTH AMERICA EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION,
2022-2028 (IN $ MILLION)
FIGURE
23: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE
TYPE, 2021 & 2028 (IN %)
FIGURE
24: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028
(IN $ MILLION)
FIGURE
25: NORTH AMERICA EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $
MILLION)
FIGURE
26: NORTH AMERICA EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY,
2022-2028 (IN $ MILLION)
FIGURE
27: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028
(IN $ MILLION)
FIGURE
28: NORTH AMERICA EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS,
2022-2028 (IN $ MILLION)
FIGURE
29: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028
(IN $ MILLION)
FIGURE
30: NORTH AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS,
2022-2028 (IN $ MILLION)
FIGURE
31: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION
DEVICE TYPES, 2022-2028 (IN $ MILLION)
FIGURE
32: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE
33: NORTH AMERICA EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS,
2022-2028 (IN $ MILLION)
FIGURE
34: NORTH AMERICA EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN
$ MILLION)
FIGURE
35: NORTH AMERICA EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN
$ MILLION)
FIGURE
36: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $
MILLION)
FIGURE
37: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028
(IN %)
FIGURE
38: UNITED STATES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
39: CANADA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)